Gwen A Melincoff

CIK 1614890 · last filed 2025-09-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.89M

Companies

7

Total Filings

29

Lifetime Open-Market Net

$15.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PLX Director 7,500 $2.09 $15.7K $0 4 2025-09-04
GANX Director $1.68 $0 4 2025-06-25
COLL Director 52,468 $34.64 $1.82M $0 5 2024-05-16
SLNO Director 666 $53.01 $35.3K $15.4K 7 2023-05-26
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director $0 2 2019-06-12
ESPR Director 6,960 $3.15 $21.9K $0 3 2019-04-29
Tobira Therapeutics, Inc. (TBRA) Delisted Director $0 3 2016-01-14

Recent Filings · Page 2 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-09-22 GANX Grant (A) $0 EDGAR
2022-09-09 PLX Grant (A) $0 EDGAR
2022-05-23 COLL Grant (A) +14,035 $0 EDGAR
2021-06-04 SLNO Grant (A) $0 EDGAR
2021-05-24 COLL Grant (A) +9,941 $0 EDGAR
2021-01-12 SLNO Grant (A) $0 EDGAR
2020-05-22 COLL Grant (A) +4,047 $0 EDGAR
2020-05-20 SLNO Grant (A) $0 EDGAR
2020-01-22 PLX Grant (A) $0 EDGAR
2019-11-20 SLNO Buy (P) +10,000 $15.4K EDGAR
Showing 1120 of 29
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.